Ovid Therapeutics (OVID) Total Liabilities (2020 - 2025)
Historic Total Liabilities for Ovid Therapeutics (OVID) over the last 6 years, with Q3 2025 value amounting to $19.2 million.
- Ovid Therapeutics' Total Liabilities fell 2736.31% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year decrease of 2736.31%. This contributed to the annual value of $23.9 million for FY2024, which is 5742.31% down from last year.
- Per Ovid Therapeutics' latest filing, its Total Liabilities stood at $19.2 million for Q3 2025, which was down 2736.31% from $21.6 million recorded in Q2 2025.
- Over the past 5 years, Ovid Therapeutics' Total Liabilities peaked at $56.2 million during Q4 2023, and registered a low of $10.1 million during Q3 2021.
- Over the past 5 years, Ovid Therapeutics' median Total Liabilities value was $23.0 million (recorded in 2022), while the average stood at $24.9 million.
- As far as peak fluctuations go, Ovid Therapeutics' Total Liabilities plummeted by 6399.9% in 2021, and later soared by 14455.0% in 2023.
- Over the past 5 years, Ovid Therapeutics' Total Liabilities (Quarter) stood at $14.8 million in 2021, then skyrocketed by 55.38% to $23.0 million in 2022, then soared by 144.55% to $56.2 million in 2023, then plummeted by 57.42% to $23.9 million in 2024, then dropped by 20.01% to $19.2 million in 2025.
- Its Total Liabilities was $19.2 million in Q3 2025, compared to $21.6 million in Q2 2025 and $22.4 million in Q1 2025.